Navamedic ASA (OSL:NAVA)
Norway · Delayed Price · Currency is NOK 19.80
-0.50 (-2.46%)
Apr 24, 2026, 3:10 PM CET
Navamedic ASA Market Cap
Navamedic ASA has a market cap or net worth of 474.83 million as of April 24, 2026. Its market cap has increased by 34.42% in one year.
Market Cap
474.83M
Enterprise Value
612.47M
Revenue
571.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
19.80
Market Cap Chart
Since March 31, 2006, Navamedic ASA's market cap has increased from 111.70M to 474.83M, an increase of 325.11%. That is a compound annual growth rate of 7.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 486.82M | -14.71% |
| Dec 30, 2025 | 570.76M | 25.74% |
| Dec 30, 2024 | 453.93M | -28.72% |
| Dec 29, 2023 | 636.85M | 5.92% |
| Dec 30, 2022 | 601.25M | 8.19% |
| Dec 30, 2021 | 555.75M | 90.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.21B |
| Circio Holding ASA | 1.98B |
| Nordhealth AS | 1.89B |
| Photocure ASA | 1.85B |
| Vistin Pharma ASA | 997.75M |
| Omda AS | 838.76M |
| Lytix Biopharma ASA | 761.31M |
| Gentian Diagnostics ASA | 681.73M |